Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

False Claims Act suit alleging that medical practices engaged in a scheme to overbill Medicare for Amgen Inc. drugs is now dismissed, a New York federal district court said.

Amgen Inc. closed $13.93 short of its 52-week high ($346.85), which the company reached on July 25th.

On June 28, 2024, the United States Patent and Trademark Office (“USPTO”) requested the public’s views on the current state ...

Rory McIlroy believes it will be difficult for Ian Poulter or Lee Westwood to be a future Ryder Cup captain because they no ...

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

Shares of Amgen Inc. AMGN slumped 0.73% to $332.80 Tuesday, on what proved to be an all-around mixed trading session for the ...

Nearly a year after Coherus BioSciences’ on-body injector for Udenyca was rejected over external production issues, a ...

We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article we ...

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

In a report released today, Michael Yee from Jefferies assigned a Buy rating to Amgen (AMGN – Research Report), with a price target of ...